Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$3.30
+2.80%
Mkt Cap $358.41M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+263.6%
Consensus $12.00 vs current $3.30
NASDAQ·Healthcare·Biotechnology
$3.30
+2.80%
Mkt Cap $358.41M
No recent rating data.
Price Target (7 analysts)
$12.00
Range $12.00 – $12.00
+263.6%
Consensus $12.00 vs current $3.30